Yusheng Ye

发表

Sora: High Performance Software Radio Using General Purpose Multi-core Processors

Haitao Wu, Geoffrey M. Voelker, He Liu, 2009, NSDI.

Assessing the safety and feasibility of metastasis-directed radiation and neoadjuvant hormone and radiation therapy followed by radical prostatectomy for treating oligometastatic prostate cancer: protocol for an open-label, dose-escalation, single-centre phase I clinical trial

Yusheng Ye, Yue Yang, Yu-Tian Xiao, 2020 .

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China

Yusheng Ye, Xu Gao, Xianzhi Zhao, 2022, Frontiers in Oncology.

Optimization of Cas9 RNA sequence to reduce its unexpected effects as a microRNA sponge

Li Zhang, Junfeng Jiang, Yusheng Ye, 2022, Molecular cancer.

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy

Yusheng Ye, T. Su, Xianzhi Zhao, 2020, Frontiers in Oncology.

Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial

Yusheng Ye, Xianzhi Zhao, Huojun Zhang, 2022, BMJ Open.

Biologically effective doses of 60-70Gy vs. >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a phase III study

Yusheng Ye, Xianzhi Zhao, Huojun Zhang, 2020 .

Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial

Yusheng Ye, Yue Yang, Yu-Tian Xiao, 2022, Cancer control : journal of the Moffitt Cancer Center.

Protocol of the integrated boost to the dominant intraprostatic nodule in stereotactic body radiation therapy for localized prostate cancer.

Yusheng Ye, Changjing Zuo, Xianzhi Zhao, 2022, Future oncology.

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

Yusheng Ye, T. Su, Xianzhi Zhao, 2020, Therapeutic advances in medical oncology.

Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles

Yusheng Ye, Xianzhi Zhao, Yuxin Shen, 2020, Cancer science.

Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.

Yusheng Ye, G. Jin, Xianzhi Zhao, 2022, The Lancet. Oncology.

Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.

Yusheng Ye, G. Jin, Xianzhi Zhao, 2021, The Lancet. Oncology.

Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial

Yusheng Ye, Xu Gao, Jing Li, 2022, BMJ Open.

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China

Yusheng Ye, Xianzhi Zhao, Huojun Zhang, 2021, Journal of Cancer Research and Clinical Oncology.

Immune profiling of pancreatic cancer for radiotherapy with immunotherapy and targeted therapy: biomarker analysis of a randomized phase 2 trial.

Yusheng Ye, Xianzhi Zhao, Huojun Zhang, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.